Changes in Immunoglobulin in Patients with Multiple Sclerosis Treated with Anti CD20 Monoclonal Antibodies

被引：0
|
作者：
Vollmer, Brandi [1 ]
Bourassa, Timber [1 ]
Dao, Vi [1 ]
Sillau, Stefan [1 ]
Alvarez, Enrique [1 ]
Nair, Kavita [1 ,2 ]
机构：
[1] Univ Colorado, Dept Neurol, Aurora, CO USA
[2] Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P286/714
引用
收藏
页码：340 / 340
页数：1
相关论文
共 50 条
  • [41] Multiple Sclerosis and disability progression in anti-CD20 treated patients: a radiomics approach
    Panzera, Ivan
    Fiscone, Cristiana
    Tonon, Caterina
    Lugaresi, Alessandra
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 561 - 561
  • [42] Increased use of anti-CD20 monoclonal antibodies (anti-CD20s) in early line treatments for relapsing remitting multiple sclerosis (RRMS) patients in Europe and the United States
    Vindici, J.
    Teoh, S.
    Goh, A. J.
    Gill, L.
    Gabriele, S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 878 - 878
  • [43] Rituxan™:: Anti CD20 monoclonal antibody for the treatment of lymphoma.
    Grillo-López, AJ
    White, CA
    Dallaire, BK
    Varns, C
    Shen, D
    McClure, A
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 746 - 746
  • [44] Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series
    Susanne Rüfenacht
    Pascal Gantenbein
    Katia Boggian
    Domenica Flury
    Lukas Kern
    Günter Dollenmaier
    Philipp Kohler
    Werner C. Albrich
    Infection, 2022, 50 : 783 - 790
  • [45] Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series
    Rufenacht, Susanne
    Gantenbein, Pascal
    Boggian, Katia
    Flury, Domenica
    Kern, Lukas
    Dollenmaier, Gunter
    Kohler, Philipp
    Albrich, Werner C.
    INFECTION, 2022, 50 (03) : 783 - 790
  • [46] Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties
    Klein, Christian
    Lammens, Alfred
    Schaefer, Wolfgang
    Georges, Guy
    Schwaiger, Manfred
    Moessner, Ekkehard
    Hopfner, Karl-Peter
    Umana, Pablo
    Niederfellner, Gerhard
    MABS, 2013, 5 (01) : 22 - 33
  • [47] Anti-lymphoma effects of recombinant bispecific monoclonal antibodies (bsMAbs) against CD20 and CD22 antigens
    Qu, Z.
    Shi, V.
    Delaney, D. L.
    Hansen, H. J.
    Chang, C-H
    Goldenberg, D. M.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2006, 21 (04) : 403 - 403
  • [48] Risk factors for developing lymphopenia and hypogammaglobulinemia in anti-cd20 treated patients with multiple sclerosis
    Vollmer, B.
    Vollmer, T.
    Corboy, J.
    Alvarez, E.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 304 - 304
  • [49] Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies
    Shan, D
    Ledbetter, JA
    Press, OW
    BLOOD, 1998, 91 (05) : 1644 - 1652
  • [50] Role of CD20 Monoclonal Antibodies in Previously Untreated Chronic Lymphocytic Leukemia
    Parikh, Sameer A.
    Wierda, William G.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 : S27 - S33
12345